Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | malate dehydrogenase, putative | 0.0573 | 0.3424 | 0.5 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0573 | 0.3424 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0573 | 0.3424 | 1 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0573 | 0.3424 | 1 |
Echinococcus granulosus | lactate dehydrogenase protein | 0.0573 | 0.3424 | 1 |
Leishmania major | malate dehydrogenase, putative | 0.0573 | 0.3424 | 0.5 |
Echinococcus granulosus | L lactate dehydrogenase B chain | 0.0573 | 0.3424 | 1 |
Echinococcus multilocularis | lactate dehydrogenase protein | 0.0573 | 0.3424 | 1 |
Wolbachia endosymbiont of Brugia malayi | malate dehydrogenase | 0.0573 | 0.3424 | 0.5 |
Plasmodium falciparum | L-lactate dehydrogenase | 0.0573 | 0.3424 | 0.5 |
Schistosoma mansoni | malate dehydrogenase | 0.0573 | 0.3424 | 0.3424 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0573 | 0.3424 | 1 |
Brugia malayi | lactate dehydrogenase. | 0.0573 | 0.3424 | 0.5 |
Echinococcus multilocularis | L lactate dehydrogenase B chain | 0.0573 | 0.3424 | 1 |
Toxoplasma gondii | lactate dehydrogenase LDH1 | 0.0573 | 0.3424 | 0.5 |
Toxoplasma gondii | malate dehydrogenase MDH | 0.0573 | 0.3424 | 0.5 |
Plasmodium falciparum | malate dehydrogenase | 0.0573 | 0.3424 | 0.5 |
Schistosoma mansoni | L-lactate dehydrogenase | 0.0573 | 0.3424 | 0.3424 |
Toxoplasma gondii | lactate dehydrogenase LDH2 | 0.0573 | 0.3424 | 0.5 |
Echinococcus granulosus | lactate dehydrogenase a | 0.0573 | 0.3424 | 1 |
Plasmodium vivax | lactate dehydrogenase | 0.0573 | 0.3424 | 0.5 |
Echinococcus multilocularis | lactate dehydrogenase a | 0.0573 | 0.3424 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0573 | 0.3424 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.